Neonatal Bilirubin External Quality Assessment
Neonatal Bilirubin External Quality Assessment
The RIQAS Neonatal Bilirubin EQA programme has been designed to assess the performance of total and direct bilirubin assays with levels tailored to neonatal bilirubin testing.
- Lyophilised for enhanced stability
- Monthly reporting
- Human based serum
- Submit results and view reports online via RIQAS.net
- Rapid turnaround of reports allows for any necessary corrective actions to be taken with minimal disruption to laboratory output
- Cycle Starts – July 2025
| Cat No | Kit Size | Frequency | Parameters | |
|---|---|---|---|---|
| RQ9191 | 2 x (6x3ml) | Monthly (1 x 12 month cycle) | 2 | |
Parameter
- Direct Bilirubin
- Total Bilirubin
Please note, product availability may vary country to country.
Complete QC solutions for results you can trust
Randox Quality Control aim to deliver the complete QC package and with our portfolio we believe we have something to offer every laboratory regardless of their size or budget.
The Randox Quality Control portfolio includes;
- Acusera true third party Quality Control’s
- Acusera 24.7 Live Online, Interlaboratory Data Management Software
- RIQAS, the world’s largest international EQA scheme
- and, Acusera Verify, dedicated calibration verifiers
Designed to streamline QC in even the most demanding laboratories our complete QC solutions will save precious time and money through consolidation, ease-of-use and high quality products.
With accurate and reliable testing at the top of a laboratory’s priority list, we at Randox Quality Control strive to put you at the top of ours.
Request your FREE QC consultation
Randox Quality Control’s specialist QC consultants can provide your laboratory with a FREE consultation to demonstrate how we can help you streamline your laboratory, meet regulatory requirements and save time and money.
Simply fill out the form below to request your consultation today.
CYFRA 21-1 External Quality Assessment
The RIQAS CYFRA 21-1 EQA programme is designed to cover the analysis of CYFRA 21-1 in clinical laboratories when monitoring the response to treatment of cancers such as non-small cell lung carcinoma, cervical, breast and bladder cancer.
- Lyophilised samples
- Monthly reporting
- Testing covers the full range of clinically relevant decision levels
- Submit results and view reports online via RIQAS.net
- 12 month subscription
- Cycle Starts – March 2025
| Cat No | Kit Size | Frequency | Parameters | |
|---|---|---|---|---|
| RQ9175 | 12 x 1ml | Monthly | 1 | |
Parameter
- CYFRA 21-1 (Cytokeratin 19 fragment)
Please note, product availability may vary country to country.
Related Products
Anti-TSH Receptor External Quality Assessment
The RIQAS Anti-TSH Receptor EQA programme is designed to cover the analysis of Anti-TSH Receptor in clinical laboratories when thyroid dysfunction is suspected.
- Lyophilised samples
- Monthly reporting
- Testing covers the full range of clinically relevant decision levels
- Submit results and view reports online via RIQAS.net
- 12 month subscription
- Cycle Starts – March 2025
| Cat No | Kit Size | Frequency | Parameters | |
|---|---|---|---|---|
| RQ9174 | 12 x 1ml | Monthly | 1 | |
Parameter
- Anti-TSH Receptor (TRAb)
Please note, product availability may vary country to country.
Related Products
Immunosuppressant External Quality Assessment
The RIQAS Immunosuppressant EQA programme has been designed to cover the analysis of Immunosuppressants in clinical laboratories. Immunosuppressants are primarily used after transplant operations to prevent the host body from rejecting donor organs.
- Lyophilised samples
- Monthly reporting
- Testing covers the full range of clinically relevant decision levels
- Submit results and view reports online via RIQAS.net
- 12 month subscription
- LC/MS reference values provided enabling participants to compare results to an accurately assigned value
- Cycle Starts – March 2025
| Cat No | Kit Size | Frequency | Parameters | |
|---|---|---|---|---|
| RQ9159 | 12 x 2ml | Monthly (1 x 12 month cycle) | 4 | |
Parameters
- Ciclosporin
- Everolimus
- Sirolimus
- Tacrolimus
Please note, product availability may vary country to country.
Related Products
Sweat Testing External Quality Assessment
The RIQAS Sweat Testing EQA programme has been designed to cover the analysis of Sweat Testing in clinical laboratories measuring the concentration of Chloride and Conductivity in sweat, used in the testing of Cystic Fibrosis (CF).
- Liquid ready-to-use samples
- Monthly reporting
- Testing covers the full range of clinically relevant decision levels
- Submit results and view reports online via RIQAS.net
- 12 month subscription
- Cycle Starts – March 2025
| Cat No | Kit Size | Frequency | Parameters | |
|---|---|---|---|---|
| RQ9173 | 12 x 2ml | Monthly | 2 | |
Parameter
- Chloride
- Conductivity
Please note, product availability may vary country to country.
CSF External Quality Assessment
The RIQAS Cerebrospinal Fluid EQA programme has been designed to monitor the performance of CSF in clinical laboratories where samples are tested to diagnose a range of medical disorders.
- Liquid ready-to-use samples
- Monthly reporting
- Testing covers the full range of clinically relevant decision levels
- Submit results and view reports online via RIQAS.net
- 12 month subscription
- Cycle Starts – March 2025
| Cat No | Kit Size | Frequency | Parameters | |
|---|---|---|---|---|
| RQ9168 | 12 x 3ml | Monthly | 7 | |
Parameters
- Albumin
- Chloride
- Glucose
- IgG
- Lactate
- Protein (Total)
- Sodium
Please note, product availability may vary country to country.